Latest News: Proscia Receives FDA 510(k) Clearance For Concentriq AP-DxREAD THE PRESS RELEASE

Cloud-based digital pathology platform helps CRO deliver more informed preclinical studies

Proscia
By Author Proscia | April 24, 2023

With today’s news, Virscio joins other life sciences organizations at the forefront of digital pathology adoption. Concentriq for Research augments its integrated in-life and histology capabilities and unparalleled access to highly translational in vivo models that truly predict risk and response to meet the expanding demands of the biotechnology and pharmaceutical companies it serves.

Our website uses cookies. By using this site, you agree to its use of cookies.